ALKERMES



Ebit Endring Dato
AbbVie USD 5.24B 1.5B 2024-12
Acadia Pharmaceuticals USD 6.99M 24.66M 2024-12
ALKERMES USD 162.69M 46.46M 2024-12
Amgen USD 4.03B 11M 2024-12
Biogen USD 644.1M 100.9M 2024-12
BioMarin Pharmaceutical USD 161.41M 47.51M 2024-12
Bristol-Myers Squibb USD 4.18B 30M 2025-03
Eli Lilly USD 3.7B 1.93B 2025-03
Gilead Sciences USD 2.89B 221M 2025-03
Ionis Pharmaceuticals USD -146000000 36M 2025-03
J&J USD 7.39B 2.04B 2025-03
Malin Corporation EUR -2200000 800K 2023-06
Merck USD 5.22B 339M 2024-12
Neurocrine Biosciences USD 142M 41.8M 2024-12
Otsuka Holdings JPY 44.75B 57.37B 2024-06
Pfizer USD 5.93B 1.31B 2025-03
Regeneron Pharmaceuticals USD 913.7M 661M 2025-03
Vertex Pharmaceuticals USD 1.2B 108.8M 2024-12



ALKERMES - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.